813 related articles for article (PubMed ID: 8827013)
21. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
22. Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery.
Deng T; Feng Y; Zheng J; Huang Q; Liu J
J Gynecol Oncol; 2015 Apr; 26(2):111-7. PubMed ID: 25872892
[TBL] [Abstract][Full Text] [Related]
23. [Follow-up of high risk, human papillomavirus (HPV)-positive patients with cancer of the uterine cervix].
Hernádi Z; Sápy T; Kónya J; Veress G; Czeglédy J
Orv Hetil; 1997 May; 138(20):1249-53. PubMed ID: 9244858
[TBL] [Abstract][Full Text] [Related]
24. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers.
Lo KW; Cheung TH; Chung TK; Wang VW; Poon JS; Li JC; Lam P; Wong YF
Gynecol Obstet Invest; 2001; 51(3):202-7. PubMed ID: 11306910
[TBL] [Abstract][Full Text] [Related]
25. Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias.
Kónya J; Veress G; Hernádi Z; Soós G; Czeglédy J; Gergely L
J Med Virol; 1995 May; 46(1):1-6. PubMed ID: 7622999
[TBL] [Abstract][Full Text] [Related]
26. The role of high risk HPV lymph node positivity in the surgical staging of cancer of the uterine cervix.
Sápy T; Hernádi Z; Lukácskó L; Borsos A
Acta Chir Hung; 1997; 36(1-4):313-5. PubMed ID: 9408386
[TBL] [Abstract][Full Text] [Related]
27. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
29. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
30. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
31. Can recurrence of cervical cancer be predicted by human papillomavirus DNA in nodes or plasma?
Peedicayil A; Sathish N; Gnanamony M; John S; Viswanathan FR; Naseema PS; Abraham P
J Low Genit Tract Dis; 2009 Apr; 13(2):102-6. PubMed ID: 19387130
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus-31-related types predict better survival in cervical carcinoma.
Huang LW; Chao SL; Hwang JL
Cancer; 2004 Jan; 100(2):327-34. PubMed ID: 14716768
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients--a prospective study.
Lukaszuk K; Liss J; Gulczynski J; Nowaczyk M; Nakonieczny M; Piatkowski M; Sliwinski W; Baay M; Wozniak I; Maj B; Lukaszuk M
Gynecol Oncol; 2007 Mar; 104(3):721-6. PubMed ID: 17156830
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
35. Prognostic significance of human papillomavirus DNA in vulvar carcinoma.
Monk BJ; Burger RA; Lin F; Parham G; Vasilev SA; Wilczynski SP
Obstet Gynecol; 1995 May; 85(5 Pt 1):709-15. PubMed ID: 7724101
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study.
Franco E; Bergeron J; Villa L; Arella M; Richardson L; Arseneau J; Stanimir G
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):271-5. PubMed ID: 8722218
[TBL] [Abstract][Full Text] [Related]
37. [Significance of pelvic lymph node human papillomavirus DNA detection in cervical cancer].
Liu GB; Liu X; Pang ZJ; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1236-9. PubMed ID: 16234097
[TBL] [Abstract][Full Text] [Related]
38. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.
Cuschieri K; Brewster DH; Graham C; Nicoll S; Williams AR; Murray GI; Millan D; Johannessen I; Hardie A; Cubie HA
Int J Cancer; 2014 Dec; 135(11):2721-6. PubMed ID: 24740764
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma.
Ikenberg H; Wiegering I; Pfisterer J; Kiechle-Schwarz M; Schmitt B; Sauerbrei W; Pfleiderer A
Cancer J Sci Am; 1996; 2(1):28-34. PubMed ID: 9166495
[TBL] [Abstract][Full Text] [Related]
40. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Obermair A; Dreier B; Birner P; Breitenecker G; Knocke TH; Selzer E; Pötter R
Int J Cancer; 2002 Nov; 102(3):237-43. PubMed ID: 12397642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
